The new facility, led by two School of Medicine researchers, provides advanced tools for exploring tiny biological machines, from viral particles to the interior of the cell.

Stanford scientists created an odd couple: a modified version of an immune-signaling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects.

Stanford scientists have developed a biochemical screen that identifies molecules critical to immunotherapy for a host of diseases, including cancer.

Daniel Chang, Howard Chang, Christopher Garcia, Amy Ladd, William Maloney, Geoffrey Tabin and Jerome Yesavage have been appointed to endowed professorships at the School of Medicine.

Stanford scientists have found a relatively simple, low-cost fix that substantially improves images obtained via a widely used optical scanning technique, opening the door to "virtual biopsies."